Nora Choque Olsson
Stockholm, Sverige, Sweden
Location contact
Markus Jansson-Fröjmark, PhD
CONTACT
Nora Choque Olsson, PhD
CONTACT
NCT Number: NCT03624400
This trial investigates the behavioural effects of Internet-based Cognitive behaviour therapy for insomnia (CBT-I) in adolescents with autism spectrum disorder with sleep problems. This is a randomised controlled trial.
Trial opening soon.
Get Notified13 year–17 year
All sexes
Interventional
Not applicable
Stockholm, Sverige, Sweden
Markus Jansson-Fröjmark, PhD
CONTACT
Nora Choque Olsson, PhD
CONTACT
Sleep problems are common in adolescents with autism spectrum disorder (ASD)1. Internet-based Cognitive behaviour therapy for insomnia (iCBT-I) is considered as an evidence-based treatment for insomnia 2. To date, no Internet-based CBT-I delivered treatment for sleep problems in adolescents with ASD has been undertaken. The objective of the study is to investigate the efficacy and effectiveness of the Internet-based CBT-I for sleep problems in adolescents with ASD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The adapted Internet-based CBT-I for adolescents with ASD includes sleep hygiene, restriction of time in bed, stimulus control, cognitive therapy, and relaxation techniques. The treatment consists of 8 weekly modules and each module consists of several website pages that will be presented in a fixed order, with preprogrammed modules containing information, interactive questionnaires, descriptions of exercises and movies.
Internet-based psychoeducation contains information about ASD, sleep difficulties and aspects of sleep hygiene. The intervention takes place in 8 weeks modules.
Time frame: Baseline, post intervention (8 weeks), 3 months post intervention follow-up and 6 months post intervention follow-up
The ISI is a seven-item measure that yields a quantitative index of sleep impairment and treatment outcome. Participants rate the following components on a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely): (a) severity of sleep-onset, sleep-maintenance, and early morning awakening problems; (b) satisfaction with current sleep pattern; (c) interference with daily functioning; (d) noticeability of impairment attributed to the sleep problem; and (e) level of distress caused by the sleep problem. Total scores range from 0 to 28, with higher scores indicating greater perceived insomnia severity.
Time frame: Baseline, post intervention (8 weeks), 3 months post intervention follow-up and 6 months post intervention follow-up
An actigraph is a small instrument worn on the wrist or ankle to measure body movement and nighttime sleep parameters.
Time frame: Baseline, post intervention (8 weeks), 3 months post intervention follow-up and 6 months post intervention follow-up
AIS is a self-administered questionnaire assessing the quality of sleep.
Time frame: Baseline, post intervention (8 weeks), 3 months post intervention follow-up and 6 months post intervention follow-up
The DD-CGAS is an instrument used by clinicians to rate patients' global everyday functioning.
Time frame: Baseline, post intervention (8 weeks), 3 months post intervention follow-up and 6 months post intervention follow-up
The SCAS is a 38-item parent report measure of children's anxiety.
Time frame: Baseline, post intervention (8 weeks), 3 months post intervention follow-up and 6 months post intervention follow-up
The DERS-16 is a brief version of self-report measure of emotion regulation difficulties.
Contact information is provided by the study sponsor or research team.
Markus Jansson-Fröjmark, Professor
CONTACT
Nora Choque Olsson, PhD
CONTACT
Stockholm University
Other
Internet-delivered Cognitive Behaviour Therapy for Sleep Problems in Adolescents with Autism Spectrum Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07277101
Autism Spectrum Disorder, Autistic Disorder
Shanghai, China
View Trial DetailsNCT06291298
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Tampa, Florida, United States
View Trial DetailsNCT06059352
Autism Spectrum Disorder, Central Auditory Processing Disorder
Loma Linda, California, United States
View Trial DetailsNCT07007819
Autism Spectrum Disorder, Child Development Disorders, Pervasive
Cleveland, Ohio, United States
View Trial Details